130 related articles for article (PubMed ID: 16339276)
1. Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I).
Ringkananont U; Van Durme J; Montanelli L; Ugrasbul F; Yu YM; Weiss RE; Refetoff S; Grasberger H
Mol Endocrinol; 2006 Apr; 20(4):893-903. PubMed ID: 16339276
[TBL] [Abstract][Full Text] [Related]
2. A newly discovered TSHR variant (L665F) associated with nonautoimmune hyperthyroidism in an Austrian family induces constitutive TSHR activation by steric repulsion between TM1 and TM7.
Jaeschke H; Schaarschmidt J; Eszlinger M; Huth S; Puttinger R; Rittinger O; Meiler J; Paschke R
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2051-9. PubMed ID: 24947036
[TBL] [Abstract][Full Text] [Related]
3. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G
J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806
[TBL] [Abstract][Full Text] [Related]
4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
5. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.
Duprez L; Parma J; Van Sande J; Allgeier A; Leclère J; Schvartz C; Delisle MJ; Decoulx M; Orgiazzi J; Dumont J
Nat Genet; 1994 Jul; 7(3):396-401. PubMed ID: 7920658
[TBL] [Abstract][Full Text] [Related]
7. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism.
Claus M; Maier J; Paschke R; Kujat C; Stumvoll M; Führer D
Thyroid; 2005 Sep; 15(9):1089-94. PubMed ID: 16187920
[TBL] [Abstract][Full Text] [Related]
8. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5.
Karges B; Krause G; Homoki J; Debatin KM; de Roux N; Karges W
J Endocrinol; 2005 Aug; 186(2):377-85. PubMed ID: 16079263
[TBL] [Abstract][Full Text] [Related]
9. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
10. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism.
Biebermann H; Schöneberg T; Hess C; Germak J; Gudermann T; Grüters A
J Clin Endocrinol Metab; 2001 Sep; 86(9):4429-33. PubMed ID: 11549687
[TBL] [Abstract][Full Text] [Related]
11. A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism.
Alberti L; Proverbio MC; Costagliola S; Weber G; Beck-Peccoz P; Chiumello G; Persani L
Eur J Endocrinol; 2001 Sep; 145(3):249-54. PubMed ID: 11517004
[TBL] [Abstract][Full Text] [Related]
12. A Japanese family with nonautoimmune hyperthyroidism caused by a novel heterozygous thyrotropin receptor gene mutation.
Nakamura A; Morikawa S; Aoyagi H; Ishizu K; Tajima T
Pediatr Res; 2014 Jun; 75(6):749-53. PubMed ID: 24608569
[TBL] [Abstract][Full Text] [Related]
13. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
[TBL] [Abstract][Full Text] [Related]
14. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor.
Govaerts C; Lefort A; Costagliola S; Wodak SJ; Ballesteros JA; Van Sande J; Pardo L; Vassart G
J Biol Chem; 2001 Jun; 276(25):22991-9. PubMed ID: 11312274
[TBL] [Abstract][Full Text] [Related]
15. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6.
Winkler F; Kleinau G; Tarnow P; Rediger A; Grohmann L; Gaetjens I; Krause G; L'Allemand D; Grüters A; Krude H; Biebermann H
J Clin Endocrinol Metab; 2010 Aug; 95(8):3605-10. PubMed ID: 20501679
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
Führer D; Wonerow P; Willgerodt H; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
[TBL] [Abstract][Full Text] [Related]
17. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse.
Stein SA; Oates EL; Hall CR; Grumbles RM; Fernandez LM; Taylor NA; Puett D; Jin S
Mol Endocrinol; 1994 Feb; 8(2):129-38. PubMed ID: 8170469
[TBL] [Abstract][Full Text] [Related]
18. Molecular Insights into the Transmembrane Domain of the Thyrotropin Receptor.
Chantreau V; Taddese B; Munier M; Gourdin L; Henrion D; Rodien P; Chabbert M
PLoS One; 2015; 10(11):e0142250. PubMed ID: 26545118
[TBL] [Abstract][Full Text] [Related]
19. An inactivating mutation within the first extracellular loop of the thyrotropin receptor impedes normal posttranslational maturation of the extracellular domain.
Sura-Trueba S; Aumas C; Carre A; Durif S; Leger J; Polak M; de Roux N
Endocrinology; 2009 Feb; 150(2):1043-50. PubMed ID: 18927215
[TBL] [Abstract][Full Text] [Related]
20. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.
Gu WX; Du GG; Kopp P; Rentoumis A; Albanese C; Kohn LD; Madison LD; Jameson JL
Endocrinology; 1995 Jul; 136(7):3146-53. PubMed ID: 7789342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
